NovAliX, Galapagos in osteoarthritis discovery research collaboration
NovAliX will discover specific small molecule lead candidates for a novel, validated osteoarthritis target chosen by Galapagos, under the collaboration. The company will identify hits using its Graffinity
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.